[1] |
Yabe H. Allogeneic hematopoietic stem cell transplantation for inherited metabolic disorders[J]. Int J Hematol, 2022, 116(1): 28-40.
doi: 10.1007/s12185-022-03383-z
pmid: 35594014
|
[2] |
Marcais A, Mahloui N, Neven B, et al. Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency[J]. Bone Marrow Transplant, 2022, 57(10): 1520-1530.
|
[3] |
刘虎, 肖佩芳, 卢俊, 等. 脐带血移植治疗儿童血液病疗效的回顾性分析[J]. 临床儿科杂志, 2017, 35(10): 769-774.
|
|
Liu H, Xiao PF, Lu J, et al. Retrospective analysis of curative effect of umbilical cord blood transplantation on children with hematologic diseases[J]. Linchuang Erke Zazhi, 2017, 35(10): 769-774.
|
[4] |
Sanchez-Petitto G, Rezvani K, Daher M, et al. Umbilical cord blood transplantation: connecting its origin to its future[J]. Stem Cells Transl Med, 2023, 12(2): 55-71.
|
[5] |
Sun Z, Yao B, Xie H, et al. Clinical progress and preclinical insights into umbilical cord blood transplantation improvement[J]. Stem Cells Transl Med, 2022, 11(9): 912-926.
|
[6] |
Chen J, Pang A, Zhao Y, et al. Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes[J]. Hematology, 2022, 27(1): 293-299.
doi: 10.1080/16078454.2022.2042064
pmid: 35192779
|
[7] |
尹光丽, 李建勇, 缪扣荣. 造血干细胞移植植入失败的研究进展[J]. 南京医科大学学报(自然科学版), 2020, 40(1): 141-146.
|
|
Yin GL, Li JY, Miao KR. Progress on graft failure of allogeneic hematopoietic stem cell transplantation[J]. Nanjing Yike Daxue Xuebao (Ziran Kexue Ban), 2020, 40(1): 141-146.
|
[8] |
Park JH, Lee JH, Lee JH, et al. Incidence, management, and prognosis of graft failure and autologous reconstitution after allogeneic hematopoietic stem cell transplantation[J]. J Korean Med Sci, 2021, 36(23): e151.
doi: 10.3346/jkms.2021.36.e151
pmid: 34128593
|
[9] |
Balduzzi A, Dalle JH, Wachowiak J, et al. Transplantation in children and adolescents with acute lymphoblastic leukemia from a matched donor versus an HLA-identical sibling: Is the outcome comparable? Results from the international BFM ALL SCT 2007 study[J]. Biol Blood Marrow Transplant, 2019, 25(11): 2197-2210.
|
[10] |
Olsson RF, Logan BR, Chaudhury S, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies[J]. Leukemia, 2015, 29(8): 1754-1762.
doi: 10.1038/leu.2015.75
pmid: 25772027
|
[11] |
顾永春, 顾兴全, 武娇, 等. 面向不平衡网络评论数据挖掘的服务质量评价[J]. 小型微型计算机系统, 2021, 42(2): 354-361.
|
|
Gu YC, Gu XQ, Wu J, et al. Service quality evaluation via mining unbalanced network reviews[J]. Xiaoxing Weixing Jisuanji Xitong, 2021, 42(2): 354-361.
|
[12] |
Ozdemir ZN, Civriz Bozdag S. Graft failure after allogeneic hematopoietic stem cell transplantation[J]. Transfus Apher Sci, 2018, 57(2): 163-167.
doi: S1473-0502(18)30132-0
pmid: 29724627
|
[13] |
McCann S. Graft failure[J]. Bone Marrow Transplant, 2020, 55(10): 1888-1889.
|
[14] |
费洋, 胡晓霞, 陈琪, 等. 异基因造血干细胞移植植入失败的危险因素分析[J]. 中华血液学杂志, 2020, 41(1): 64-68.
|
|
Fei Y, Hu XX, Chen Q, et al. Risk-factors analysis of graft failure after allogeneic hematopoietic stem cell transplantation[J]. Zhonghua Xueyexue Zazhi, 2020, 41(1): 64-68.
|
[15] |
Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016, 127(20): 2391-2405.
doi: 10.1182/blood-2016-03-643544
pmid: 27069254
|
[16] |
Mata JR, Zahurak M, Rosen N, et al. Graft Failure Incidence, risk Factors, and outcomes in patients undergoing non-myeloablative allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide[J]. Transplant Cell Ther, 2024, 30(6): 588-596.
doi: 10.1016/j.jtct.2024.03.018
pmid: 38521411
|
[17] |
Hong KT, Kang HJ, Kim NH, et al. Peri-engraftment syndrome in allogeneic hematopoietic SCT[J]. Bone Marrow Transplant, 2013, 48(4): 523-528.
|
[18] |
Park M, Lee SH, Lee YH, et al. Pre-engraftment syndrome after unrelated cord blood transplantation: a predictor of engraftment and acute graft-versus-host disease[J]. Biol Blood Marrow Transplant, 2013, 19(4): 640-646.
|
[19] |
郑昌成. 非血缘脐血移植植入前综合征的临床与基础研究[D]. 山东大学, 2014.
|
|
Zheng CC. Pre-engraftment syndrome after unrelated cord blood transplantation: clinical and basic research[D]. Shandong University, 2014.
|
[20] |
Sawada A, Inoue M, Koyama-Sato M, et al. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases[J]. Biol Blood Marrow Transplant, 2014, 20(2): 214-221.
|
[21] |
熊思伟, 刘玉琳. 基于Borderline-SMOTE算法与Stacking集成学习的前列腺肿瘤风险预测研究[J]. 现代肿瘤医学, 2023, 31(16): 3075-3081.
|
|
Xiong SW, Liu YL. Risk prediction study of prostate tumors based on Borderline-SMOTE algorithm and Stacking ensemble learning[J]. Xiandai Zhongliu Yixue, 2023, 31(16): 3075-3081.
|
[22] |
郑志方, 敬小青, 刘利蕊, 等. 儿童原发性肾病综合征复发相关因素分析及风险预测模型构建[J]. 临床儿科杂志, 2023, 41(12): 914-918.
|
|
Zheng ZF, Jing XQ, Liu LR, et al. Related factors analysis of recurrence and risk prediction model construction for primary nephrotic syndrome in children[J]. Linchuang Erke Zazhi, 2023, 41(12): 914-918.
|
[23] |
中华医学会儿科学分会血液学组. 儿童恶性血液病脐带血移植专家共识[J]. 中华儿科杂志, 2016, 54(11): 804-807.
|
|
Chinese Medical Association. Expert consensus on umbilical cord blood transplantation for pediatric malignant hematological diseases[J]. Zhonghua Erke Zazhi, 2016, 54(11): 804-807.
|